Gavi funding guidelines

Gavi has published Release 2 of the Gavi 6.0 Funding Guidelines, which replaces the previous version on the website. The Funding Guidelines remain the main country-facing reference for Gavi 6.0 funding guidance and should be used by countries and partners to support application development.

The full updated guidance is available as a PDF, and users can also access the interactive Funding Guidelines platform, which allows them to navigate the guidance by section and use search and filter functions to find relevant information more easily.

Release 2 consolidates priority updates and clarifications into the existing guidance. The main updates are:

• Revised HSS Investment Areas annex: Annex 4 has been updated to provide clearer and more differentiated guidance across transition segments and fragile/conflict settings. The annex has also been restructured to better show how the Gavi 6.0 Health Systems Strategy translates into potential investment areas.
• Expanded Partner Conflict of Interest guidance: Annex 5 now includes approved guidance on the role of Expanded Partners in country application development.
• New Campaign Optimisation annex: A new Annex 10 has been added to operationalise the recently board approved Gavi 6.0 Campaign Optimisation Strategic Approach. It covers efficient campaign design, integrated campaign approaches and co-financing incentive, monitoring, evaluation and learning options (Annex 10A), and the use of digital payments for campaign-workers where digital ecosystems are sufficiently mature (Annex 10B).
• Revised HSIS policy on vaccine implementation support: Guidance has been added on implementation support for vaccine introductions, preventive campaigns and planned switches in the Guaranteed Vaccine Budget. It clarifies that associated funding may be used flexibly within the Cash Budget, provided the vaccine activity is included in the country’s application and budget and proceeds, as funding remains conditional on implementation of the corresponding guaranteed vaccine activity.

Additional updates have also been made across the guidelines including the Catalytic Phase support section, Gavi Resilience Mechanism guidance, Monitoring section, Process annex (Annex 2), vaccine-specific guidance (Annex 3), Budget Eligibility annex (Annex 7), and Grant Accountability Framework (Annex 9).

Together, these updates provide countries and partners with new guidance and important clarifications to support the planning and development of Gavi 6.0 funding applications.